UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in NKTR — Nektar Therapeutics
CIK 861177
NEW YORK, NY
Position in NKTR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,286,095
+$837,998 QoQ
Shares Held
47,072
+38.3% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 239 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. NKTR ranks #80 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in NKTR
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,286,095 | 47,072 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,448,097 | 34,025 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $684,259 | 16,184 | Shares | Sole | 2026-02-13 | |
| 2023-06-30 | $121,023 | 208,662 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $146,062 | 208,662 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $377,822 | 167,179 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $534,971 | 167,179 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $740,625 | 194,902 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,638,417 | 303,974 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,533,631 | 261,557 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,666,275 | 259,815 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,458,423 | 259,815 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,051,720 | 252,586 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,319,581 | 254,093 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $3,630,952 | 218,864 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,959,874 | 214,157 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,398,666 | 246,424 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||